Authors:
Chidiac, C
Bruxelle, J
Daures, JP
Xuan, TH
Morel, P
Leplege, A
El Hasnaoui, A
de Labareyre, C
Citation: C. Chidiac et al., Characteristics of patients with herpes zoster on presentation to practitioners in France, CLIN INF D, 33(1), 2001, pp. 62-69
Authors:
Piketty, C
Jayle, D
Leplege, A
Castiel, P
Ecosse, E
Gonzalez-Canali, G
Sabatier, B
Boulle, N
Debuire, B
Le Bouc, Y
Baulieu, EE
Kazatchkine, MD
Citation: C. Piketty et al., Double-blind placebo-controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease, CLIN ENDOCR, 55(3), 2001, pp. 325-330
Authors:
Wolkenstein, P
Zeller, J
Revuz, J
Ecosse, E
Leplege, A
Citation: P. Wolkenstein et al., Quality-of-life impairment in neurofibromatosis type 1 - A cross-sectionalstudy of 128 cases, ARCH DERMAT, 137(11), 2001, pp. 1421-1425
Citation: P. Lips et A. Leplege, Development and validation of a quality of life questionnaire for patientswith vertebral fractures: Qualeffo-41, QUAL LIFE R, 9(6), 2000, pp. 763-766
Authors:
Lips, P
Cooper, C
Agnusdei, D
Caulin, F
Egger, P
Johnell, O
Kanis, JA
Kellingray, S
Leplege, A
Liberman, UA
McCloskey, E
Minne, H
Reeve, J
Reginster, JY
Scholz, M
Todd, C
de Vernejoul, MC
Wiklund, I
Citation: P. Lips et al., Quality of life in patients with vertebral fractures: Validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO), OSTEOPOR IN, 10(2), 1999, pp. 150-160